Myoforte Therapeutics, Inc.
PrivateLast Round
Corporate Funding
Dec 1, 2024
Total Funding Raised
$85M
Company Overview
Myoforte Therapeutics, Inc. is a biopharmaceutical company that develops small molecule drugs designed to enhance muscle regeneration and strength by targeting muscle stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myoforte Therapeutics, Inc. Comparables
Compare Myoforte Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epirium Bio | 90% | |
| Sarcomatrix Therapeutics Corp. | 85% | |
| Rejuvenate Biomed | 81% | |
Myoforte Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 1, 2024 | ||||
| Series A | Dec 18, 2019 |
Myoforte Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A, Corporate Funding |
| Vertex Ventures HC | Series A, Corporate Funding |
| ARCH Venture Partners | Series A, Corporate Funding |
| Bluebird Ventures | Series A, Corporate Funding |
| The Longevity Fund | Series A, Corporate Funding |
| Adams Street Partners | Series A, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2024
Raised corporate funding from ARCH Venture Partners and others.
- Dec 18, 2019
$85M round with ARCH Venture Partners and Bluebird Ventures.
Myoforte Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myoforte Therapeutics, Inc.'s valuation, stock price, and market status.